• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

[随机治疗试验的方法学质量评估]

[Evaluation of the methodological quality of randomized therapeutic trials].

作者信息

Poynard T

机构信息

Service d'Hépato-Gastro-Entérologie, Hôpital Antoine Béclère, Clamart.

出版信息

Presse Med. 1988 Feb 27;17(7):315-8.

PMID:2966351
Abstract

A grid devised to evaluate the methodological quality of randomized therapeutic trials is presented. Fourteen items are analysed: description of the principal criterion of assessment, criteria of inclusion, number of subjects seen and excluded, number of subjects randomized to each group, number of subjects excluded who are alive or lost to follow-up and reasons for the fall-outs, blind character of the doctors, patients and persons responsible for the assessment criteria, calculation of the number of subjects required before starting the trial, method of randomization and its blind character, analysis and discussion of covariables, statistical tests used, taking into account of the fall-outs and power of the trials with non-significant results. This grid, used for the analysis of 527 randomized trials, showed that about one-half of them were of mediocre quality, the most frequent defects encountered being the multiplicity of assessment criteria, the lack of description of the subjects excluded, the absence of calculation of the number of subjects required before starting the trial and the small number of subjects in trials with non-significant results.

摘要

本文介绍了一种用于评估随机治疗性试验方法学质量的表格。分析了14个项目:主要评估标准的描述、纳入标准、观察和排除的受试者数量、随机分配到每组的受试者数量、排除的存活或失访受试者数量及其退出原因、医生、患者和负责评估标准人员的盲法特征、试验开始前所需受试者数量的计算、随机化方法及其盲法特征、协变量的分析和讨论、使用的统计检验、对退出情况的考虑以及无显著结果试验的效能。使用该表格对527项随机试验进行分析,结果显示约一半试验质量一般,最常见的缺陷是评估标准多样、未描述排除的受试者、试验开始前未计算所需受试者数量以及无显著结果试验中的受试者数量较少。

相似文献

1
[Evaluation of the methodological quality of randomized therapeutic trials].[随机治疗试验的方法学质量评估]
Presse Med. 1988 Feb 27;17(7):315-8.
2
Trial design and reporting standards for intra-arterial cerebral thrombolysis for acute ischemic stroke.急性缺血性脑卒中动脉内脑溶栓的试验设计与报告标准。
Stroke. 2003 Aug;34(8):e109-37. doi: 10.1161/01.STR.0000082721.62796.09. Epub 2003 Jul 17.
3
Antiemetic studies: a methodological discussion.止吐研究:方法学探讨
Cancer Treat Rep. 1986 May;70(5):555-63.
4
Reporting on methods in clinical trials.临床试验方法报告。
N Engl J Med. 1982 Jun 3;306(22):1332-7. doi: 10.1056/NEJM198206033062204.
5
Studies with group treatments required special power calculations, allocation methods, and statistical analyses.对于组治疗的研究,需要特殊的功效计算、分配方法和统计分析。
J Clin Epidemiol. 2012 Feb;65(2):138-46. doi: 10.1016/j.jclinepi.2011.05.007. Epub 2011 Sep 9.
6
Treatment of gastric ulcer. The randomized clinical trials from 1964 to 1974 and their impact.
Am J Gastroenterol. 1978 Mar;69(3 Pt 1):272-82.
7
[Assessment of the quality of clinical therapeutic research published in Chinese Journal of Pediatrics].《对发表于<中华儿科杂志>的临床治疗性研究质量的评估》
Zhonghua Er Ke Za Zhi. 2013 Jan;51(1):29-33.
8
General statistical design considerations of randomized clinical trials.随机临床试验的一般统计设计考量
Prog Clin Biol Res. 1988;264:61-70.
9
Clinical trials:randomization before consent.临床试验:在获得同意前进行随机分组。
Biomedicine. 1981 Sep;34(2):65-6.
10
[Randomization for controlled therapeutic trials].[对照治疗试验的随机化]
Wien Klin Wochenschr. 1982 Nov 26;94(22):604-9.

引用本文的文献

1
Benefit of combination β-blocker and endoscopic treatment to prevent variceal rebleeding: a meta-analysis.联合β受体阻滞剂和内镜治疗预防静脉曲张再出血的益处:一项荟萃分析。
World J Gastroenterol. 2010 Dec 21;16(47):5982-92. doi: 10.3748/wjg.v16.i47.5982.
2
Hirsch index and truth survival in clinical research.Hirsch 指数与临床研究中的真实存活。
PLoS One. 2010 Aug 6;5(8):e12044. doi: 10.1371/journal.pone.0012044.
3
Interferon for interferon naive patients with chronic hepatitis C.用于初治慢性丙型肝炎患者的干扰素
Cochrane Database Syst Rev. 2002;2002(2):CD000370. doi: 10.1002/14651858.CD000370.
4
Interferon for acute hepatitis C.用于急性丙型肝炎的干扰素。
Cochrane Database Syst Rev. 2002;2001(1):CD000369. doi: 10.1002/14651858.CD000369.
5
Evaluation of the methodological quality of clinical trial protocols. A preliminary experience in Spain.评估临床试验方案的方法学质量。西班牙的初步经验。
Eur J Clin Pharmacol. 1993;44(4):401-2. doi: 10.1007/BF00316482.
6
[How effective is the teaching of critical analysis of scientific publications? Review of studies and their methodological quality].[科学出版物批判性分析教学的效果如何?研究及其方法学质量综述]
CMAJ. 1993 Mar 15;148(6):945-52.
7
[Risk of pregnancy complications associated with residency].[与住院医师培训相关的妊娠并发症风险]
CMAJ. 1994 Jun 1;150(11):1783-9.
8
Pharmacodynamics of vecuronium in patients with and without renal failure: a meta-analysis.维库溴铵在肾衰竭和非肾衰竭患者中的药效学:一项荟萃分析。
Can J Anaesth. 1993 Aug;40(8):696-702. doi: 10.1007/BF03009763.